Literature DB >> 15780627

Structure-activity relationship study of novel tissue transglutaminase inhibitors.

Eric Duval1, April Case, Ross L Stein, Gregory D Cuny.   

Abstract

Thieno[2,3-d]pyrimidin-4-one acylhydrazide derivatives were discovered as moderately potent inhibitors of TGase 2 (tissue transglutaminase) utilizing a fluorescence-based assay that measured TGase 2 catalyzed incorporation of the dansylated Lys derivative alpha-N-Boc-Lys-CH(2)-CH(2)-dansyl into the protein substrate N,N-dimethylated-casein. A SAR study revealed that the acylhydrazide thioether side-chain and the thiophene ring were critical to inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780627     DOI: 10.1016/j.bmcl.2005.02.005

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

Review 1.  The Gewald multicomponent reaction.

Authors:  Yijun Huang; Alexander Dömling
Journal:  Mol Divers       Date:  2010-02-27       Impact factor: 2.943

Review 2.  Therapeutic approaches for celiac disease.

Authors:  Nicholas M Plugis; Chaitan Khosla
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-05-09       Impact factor: 3.043

Review 3.  Role of transglutaminase 2 in celiac disease pathogenesis.

Authors:  Cornelius Klöck; Thomas R Diraimondo; Chaitan Khosla
Journal:  Semin Immunopathol       Date:  2012-03-22       Impact factor: 9.623

Review 4.  Substrates, inhibitors, and probes of mammalian transglutaminase 2.

Authors:  Ruize Zhuang; Chaitan Khosla
Journal:  Anal Biochem       Date:  2019-12-24       Impact factor: 3.365

Review 5.  Regulation of the activities of the mammalian transglutaminase family of enzymes.

Authors:  Cornelius Klöck; Chaitan Khosla
Journal:  Protein Sci       Date:  2012-11-09       Impact factor: 6.725

6.  Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2.

Authors:  Cornelius Klöck; Xi Jin; Kihang Choi; Chaitan Khosla; Peter B Madrid; Andrew Spencer; Brian C Raimundo; Paul Boardman; Guido Lanza; John H Griffin
Journal:  Bioorg Med Chem Lett       Date:  2010-12-16       Impact factor: 2.823

7.  Ethyl 2-(3,3-dibutyl-thio-ureido)-4,5,6,7-tetra-hydro-benzo[b]thio-phene-3-carboxyl-ate.

Authors:  Hong-Mei Wang; Jing Xu; Xiao-Hua Zeng; Jia-Hua Tian
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-11-14

8.  3-Isopropyl-2-p-tol-yloxy-5,6,7,8-tetra-hydro-1-benzothieno[2,3-d]pyrimidin-4(3H)-one.

Authors:  Xiao-Hua Zeng; Shou-Heng Deng; Yong-Nian Qu; Hong-Mei Wang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-04-30

Review 9.  Transglutaminases and neurodegeneration.

Authors:  Thomas M Jeitner; John T Pinto; Boris F Krasnikov; Mark Horswill; Arthur J L Cooper
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

Review 10.  Transglutaminase 2 inhibitors and their therapeutic role in disease states.

Authors:  Matthew Siegel; Chaitan Khosla
Journal:  Pharmacol Ther       Date:  2007-05-13       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.